TITLE

ARMY JOINS MALARIA VACCINE INITIATIVE FOR KENYA TRIAL

PUB. DATE
June 2002
SOURCE
Worldwide Biotech;Jun2002, Vol. 14 Issue 6, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the field trials of a malaria vaccine candidate launched by the Malaria Vaccine Initiative, the Walter Reed Army Institute of Research, the Kenya Medical Research Institute and the U.S. Agency for International Development.
ACCESSION #
6772518

 

Related Articles

  • The Current Status of Malaria Vaccines. Stoute, J.A.; Ballou, W.R. // BioDrugs;1998, Vol. 10 Issue 2, p123 

    A vaccine against Plasmodium falciparum malaria is needed now more than ever due the resurgence of the parasite and the increase in drug resistance. However, success in developing an effective malaria vaccine has been elusive. Among pre-erythrocytic antigens, the major antigen coating the...

  • Reply to Malaria vaccine research?setting the record straight. Waters, Andrew P.; Sauerwein, Robert; Arnot, David // Nature Medicine;Mar2000, Vol. 6 Issue 3, p234 

    Comments on the news article published in a 1999 issue of 'Nature Medicine,' magazine about malaria vaccine research. Impression of a competition between European and American malaria researchers and a discontinuation of clinical testing in Europe; Objection to the article's political connotation.

  • Malaria vaccine research?setting the record straight. Waters, Andrew P.; Sauerwein, Robert; Arnot, David // Nature Medicine;Mar2000, Vol. 6 Issue 3, p234 

    Responds to the readers comments on the article published in a 1999 issue of 'Nature Medicine' about malaria vaccine research. Interviews of members of the malaria research community during the research; Lack of support from the European Commission on the vaccine research.

  • MALARIA VACCINE TRIAL SHOWS PROMISING RESULTS.  // Indian Journal of Medical Sciences;Oct2004, Vol. 58 Issue 10, p457 

    Discusses the results of a clinical trial on a malaria vaccine completed by the World Health Organization and its benefits for protecting children with malaria in Africa. Role of African governments, research institutions and scientists in the malaria endemic areas of Africa; Preventive...

  • T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children. Ansong, Daniel; Asante, Kwaku P.; Vekemans, Johan; Owusu, Sandra K.; Owusu, Ruth; Brobby, Naana A. W.; Dosoo, David; Osei-Akoto, Alex; Osei-Kwakye, Kingsley; Asafo-Adjei, Emmanuel; O.^Boahen, Kwadwo; Sylverken, Justice; Adjei, George; Sambian, David; Apanga, Stephen; Kayan, Kingsley; Janssens, Michel H.; Lievens, Marc J. J.; Olivier, Aurelie C.; Jongert, Erik // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Background: The Plasmodium falciparum pre-erythrocytic stage candidate vaccine RTS,S is being developed for protection of young children against malaria in sub-Saharan Africa. RTS,S formulated with the liposome based adjuvant AS01E or the oil-in-water based adjuvant AS02D induces P. falciparum...

  • AMANET An Endeavor in Human Capacity Development at the Base of the Pyramid.  // Bio Partnerships Asia;Aug/Sep2013, Vol. 5 Issue 2, p10 

    The article reports on the African Malaria Network Trust (AMANET) and its efforts on treating protozoal infection in the continent. It mentions its reorganization in 2002 as well as aim in planning and conducting vaccine trials for the infective disease. It notes its aid in addressing the...

  • Global malaria vaccine effort under way.  // Public Health Reports;May/Jun94, Vol. 109 Issue 3, p465 

    Informs that scientists have overcome two obstacles in the effort to develop a malaria vaccine. Human trials of the vaccine called SPf66; Other aspects.

  • A vaccine for malaria? Engers, Howard; Mattock, Nina // World Health;May/Jun98, Vol. 51 Issue 3, p12 

    Provides information on malaria vaccine. Stages of malaria vaccines; Details on other malaria vaccine developments; Problem in developing malaria vaccine.

  • Malaria vaccine claims disputed.  // Nature;9/19/1996, Vol. 383 Issue 6597, p210 

    Reports on the controversy surrounding the alleged anti-malaria vaccine SPf66 developed in Colombia. The results of trials suggesting it has no effect on the disease.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics